These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2467523)

  • 1. Clonidine in the treatment of mixed bipolar disorder.
    Kontaxakis V; Markianos M; Markidis M; Stefanis C
    Acta Psychiatr Scand; 1989 Jan; 79(1):108-10. PubMed ID: 2467523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid.
    Sack RL; Goodwin FK
    Arch Gen Psychiatry; 1974 Nov; 31(5):649-54. PubMed ID: 4613319
    [No Abstract]   [Full Text] [Related]  

  • 4. Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology.
    Markianos M; Botsis A; Arvanitis Y
    Biol Psychiatry; 1992 Aug; 32(3):288-92. PubMed ID: 1384728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical variables in delusional depression.
    Lykouras E; Markianos M; Malliaras D; Stefanis C
    Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodevelopmental aspects of conduct disorder in boys.
    Gabel S; Stadler J; Bjorn J; Shindledecker R; Bowden CL
    Child Psychiatry Hum Dev; 1993; 24(2):125-41. PubMed ID: 7507018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
    Hatzimanolis J; Lykouras L; Markianos M; Oulis P
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of monoamine oxidase A inhibition on plasma biogenic amine metabolites in depressed patients.
    Markianos M; Alevizos B; Hatzimanolis J; Stefanis C
    Psychiatry Res; 1994 Jun; 52(3):259-64. PubMed ID: 7527564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma.
    Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR
    Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys.
    Rogeness GA; Javors MA; Maas JW; Macedo CA; Fischer C
    Biol Psychiatry; 1987 Sep; 22(9):1158-62. PubMed ID: 3651534
    [No Abstract]   [Full Text] [Related]  

  • 13. Dexamethasone increases plasma HVA but not MHPG in normal humans.
    Wolkowitz OM; Sutton ME; Doran AR; Labarca R; Roy A; Thomas JW; Pickar D; Paul SM
    Psychiatry Res; 1985 Oct; 16(2):101-9. PubMed ID: 3865250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clonidine on central and peripheral catecholamine metabolism.
    Martin PR; Ebert MH; Gordon EK; Linnoila M; Kopin IJ
    Clin Pharmacol Ther; 1984 Mar; 35(3):322-7. PubMed ID: 6199153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia.
    Kuniyoshi M; Nakamura J; Miura C; Inanaga K
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):339-46. PubMed ID: 7516085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
    Tripodianakis J; Markianos M
    Pharmacopsychiatry; 1986 Sep; 19(5):365-7. PubMed ID: 3534900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.
    Markianos E; Backman H
    J Neural Transm; 1976; 39(1-2):79-93. PubMed ID: 988114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
    Oades RD; Klimke A; Henning U; Rao ML
    Hum Psychopharmacol; 2002 Jan; 17(1):15-27. PubMed ID: 12404703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study.
    Kurita M; Nishino S; Numata Y; Okubo Y; Sato T
    PLoS One; 2014; 9(6):e100634. PubMed ID: 24971450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.